Search results (1034)
« Back to PublicationsEvaluating Asthma Clinical Remission with Inhaled Therapy: Post Hoc Analyses of CAPTAIN.
Journal article
Oppenheimer J. et al, (2026), Advances in therapy, 43, 729 - 749
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE).
Journal article
Chupp G. et al, (2026), American journal of respiratory and critical care medicine
Shaping the Future of Respiratory Care: A look into the next decade and strategic recommendations by EUFOREA.
Journal article
Bertels X. et al, (2026), Chest
Normal FEV1 without Reversibility in Asthma Trials: A Placebo Patient-Level Meta-Analysis
Journal article
Couillard S. et al, (2025), American Journal of Respiratory and Critical Care Medicine, 211, 2396 - 2399
cceptability and feasibility of biomarkers of airway eosinophilic inflammation for the management of preschool wheeze: a qualitative study.
Journal article
Perikleous A. et al, (2025), Archives of disease in childhood
Understanding the relationship between eosinophils and chronic obstructive pulmonary disease. A new dawn?
Journal article
Tiedeman C. and Pavord I., (2025), Expert review of respiratory medicine, 1 - 9
Misconceptions of Traits to Predict Response to Inhaled Corticosteroid and Bronchodilator Therapies in Asthma: A Narrative Review.
Journal article
Brusselle G. et al, (2025), Pulmonary therapy
Biological Therapies in Chronic Obstructive Pulmonary Disease: New Directions in Personalised Respiratory Medicine
Journal article
Mappin-Kasirer B. and Pavord ID., (2025), BioDrugs, 39, 827 - 839
Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5/5Rα therapy: a prospective observational study
Journal article
Howell I. et al, (2025), European Respiratory Journal, 66, 2501229 - 2501229
The Risk–Benefit Balance of Oral Corticosteroid Treatment for Asthma Attacks: A Discrete Choice Experiment of Patients and Healthcare Professionals in the UK and New Zealand
Journal article
Howell I. et al, (2025), Respirology, 30, 1035 - 1045
Transient early blood eosinophil increases do not affect dupilumab's long-term efficacy in patients with moderate-to-severe asthma.
Journal article
Pavord ID. et al, (2025), The Journal of allergy and clinical immunology
n anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trial.
Journal article
Bruce P. et al, (2025), EClinicalMedicine, 89
Reframing remission in severe asthma: a conceptual framework for distinguishing disease activity versus damage.
Journal article
Porsbjerg C. et al, (2025), The Lancet. Respiratory medicine, 13, 1026 - 1040
nalysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma.
Journal article
McDowell PJ. et al, (2025), The Journal of allergy and clinical immunology, 156, 911 - 922
Lymphoma in patients with asthma treated with dupilumab: much ado about nothing?
Journal article
Davies TJ. and Pavord ID., (2025), The European respiratory journal, 66